New diabetes clinical trial: Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
Published on: February 12, 2026 at 11:00PM Conditions : Muscle Wasting; Obesity & Overweight; Obesity Interventions : Drug: BIO101; Other: Placebo; Drug: Semaglutide Sponsors : Biophytis Not yet recruiting https://ift.tt/Ehb9wZU